0001178913-26-003617 Sample Contracts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 28th, 2026 • Entera Bio Ltd. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 26, 2026, between Entera Bio Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each purchaser, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 28th, 2026 • Entera Bio Ltd. • Biological products, (no disgnostic substances)
Note: If “no” to Section 3(d), the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.
PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT ENTERA BIO LTD.Pre-Funded Warrant Agreement • July 28th, 2026 • Entera Bio Ltd. • Biological products, (no disgnostic substances)
THIS PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [HOLDER] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Entera Bio Ltd., a company organized under the laws of the State of Israel (the “Company”), up to [·] Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section Section 2.b). The Warrant is being issued pursuant to that certain Securities Purchase Agreement, dated July 26, 2026, among the Company and the purchasers signatory thereto, as amended and/or restated from time to time (the “Purchase Agreement”).